Related Experiment Video
Updated: Apr 5, 2026
07:07
A Melanoma Patient-Derived Xenograft Model
Published on: May 20, 2019
13.4K
Nucleoside Analog Activity in Malignant Melanoma Cell Lines
1a Centre for Biomedical Resources , Linköping University , Linköping , Sweden.
Nucleosides, Nucleotides & Nucleic Acids
|August 8, 2015
Summary
Mitochondrial deoxyguanosine kinase (dGK) activates cytotoxic nucleoside analogs (NAs). Unexpectedly, reducing dGK in melanoma cells increased NA sensitivity, possibly due to enhanced thymidine kinase 2 activity.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Mitochondrial deoxyguanosine kinase (dGK) activates nucleoside analogs (NAs), crucial for their cytotoxic effects, particularly in hematological cancers.
- Malignant melanoma cell lines exhibit high sensitivity to NAs, attributed to elevated dGK expression.
Purpose of the Study:
- To investigate the role of dGK in NA sensitivity in melanoma cells.
- To explore the impact of dGK downregulation on NA cytotoxicity in the RaH5 melanoma cell line.
Main Methods:
- Screening of malignant melanoma cell lines against various nucleoside analogs.
- Downregulation of dGK expression using small interfering RNA (siRNA) in the RaH5 melanoma cell line.
- Assessing cell sensitivity to NAs post-dGK downregulation.
Main Results:
- Melanoma cell lines showed significant sensitivity to several NAs.
- Contrary to expectations, siRNA-mediated dGK downregulation in RaH5 cells led to increased sensitivity to NAs.
- Transfected cells exhibited increased activity of thymidine kinase 2, potentially explaining the heightened sensitivity.
Conclusions:
- dGK downregulation does not confer resistance to NAs in melanoma cells and can paradoxically enhance sensitivity.
- Thymidine kinase 2 activity may play a compensatory role in NA activation when dGK levels are reduced in melanoma.
Related Concept Videos
02:34Inhibition of Cdk Activity
6.2K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K
02:23Abnormal Proliferation
5.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K